Abstract
The present invention provides mutant alpha 1-antitrypsin proteins, pharmaceutical compositions comprising the same, and methods of use thereof in treatment of subjects with an inflammatory disease or disorder.
| Original language | English |
|---|---|
| Patent number | US20200140524A1 |
| State | Published - 7 May 2020 |